<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39468071</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2059-0105</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>NPJ vaccines</Title><ISOAbbreviation>NPJ Vaccines</ISOAbbreviation></Journal><ArticleTitle>Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination.</ArticleTitle><Pagination><StartPage>203</StartPage><MedlinePgn>203</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41541-024-00984-z</ELocationID><Abstract><AbstractText>We appreciate your interest in our study. This study contrasts with Dorney et al.'s focus on the first 21 days. We conducted a re-analysis regarding selection bias and found consistent results. Our research highlights the elevated risk of retinal vascular occlusion after vaccination, which can last up to two years. We also discussed the differences in study design and the effects of different vaccine brands.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing-Xing</ForeName><Initials>JX</Initials><Identifier Source="ORCID">0000-0003-3776-5042</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu-Hsun</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bair</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Wills Eye Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Shu-Bai</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0009-0009-9698-5695</Identifier><AffiliationInfo><Affiliation>College of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Connie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Optometry, Chung Shan Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Optometry, Chung Shan Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>James Cheng-Chung</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China. jccwei@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. jccwei@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Allergy, Immunology &amp; Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan. jccwei@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. jccwei@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Ju</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-7880-9198</Identifier><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung, Taiwan. doctoraga@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wills Eye Hospital, Philadelphia, PA, USA. doctoraga@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Optometry, Asia University, Taichung, Taiwan. doctoraga@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Vaccines</MedlineTA><NlmUniqueID>101699863</NlmUniqueID><ISSNLinking>2059-0105</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39468071</ArticleId><ArticleId IdType="doi">10.1038/s41541-024-00984-z</ArticleId><ArticleId IdType="pii">10.1038/s41541-024-00984-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dorney, I., Shaia, J., Kaelber, D. C., Talcott, K. E. &amp; Singh, R. P. Risk of new retinal vascular occlusion after mRNA COVID-19 vaccination within aggregated electronic health record data. JAMA Ophthalmol. 141, 441–447 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2023.0610</ArticleId><ArticleId IdType="pubmed">37052897</ArticleId><ArticleId IdType="pmc">10102921</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J. X. et al. Risk assessment of retinal vascular occlusion after COVID-19 vaccination. NPJ Vaccines. 8, 64 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-023-00661-7</ArticleId><ArticleId IdType="pubmed">37130882</ArticleId><ArticleId IdType="pmc">10153772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, Y. K. &amp; Huang, Y. H. Ocular manifestations after receiving COVID-19 vaccine: a systematic review. Vaccines (Basel). 9, 1404 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9121404</ArticleId><ArticleId IdType="pubmed">34960150</ArticleId><ArticleId IdType="pmc">8709261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski, S. R. et al. Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis. Front Immunol. 12, 779453 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.779453</ArticleId><ArticleId IdType="pubmed">34887867</ArticleId><ArticleId IdType="pmc">8649717</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>